Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001686 · ClinicalTrials.gov registry record
Evaluation, Treatment, and Natural History of Children and Young Adults With Cancer or Rare Diseases
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 482
- Enrollment target
NCT00001686: Completed study, sponsored by National Cancer Institute (NCI).
NCT00001686 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 482 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00001686 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 482 participants
- Enrollment target
Study Summary
This protocol is designed to evaluate children with cancer who appear to be probable candidates for future protocol entry or have disease manifestations that are of unique scientific importance or educational value.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 482 participants |
| Start Date | 1998-03-19 |
| Est. Completion | 2020-09-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00001686
The ClinicalTrials.gov registry entry for NCT00001686 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 482 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00001686 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00001686 about?
NCT00001686 is a clinical study titled "Evaluation, Treatment, and Natural History of Children and Young Adults With Cancer or Rare Diseases". This protocol is designed to evaluate children with cancer who appear to be probable candidates for future protocol entry or have disease manifestations that are of unique scientific importance or educational value.
What is the current status of trial NCT00001686?
This trial is currently completed. The enrollment target is 482 participants. The study started on 1998-03-19. Estimated completion is 2020-09-02.
Who is sponsoring clinical trial NCT00001686?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.